Literature DB >> 9130505

In vivo analysis of the cytoplasmic domain of mIgE antibodies.

G Achatz1, M C Lamers.   

Abstract

All immunoglobulin molecules exist in two forms, one integrated into the plasma membrane and displayed on the cell surface as the B cell receptor [1], the other secreted into tissue fluids as the soluble antibodies. Any given B lymphocyte has the potential of producing both forms. The membrane-bound form and the secreted form produced by a single B cell have identical light chains and identical heavy chains except for a short segment at the C terminus. This segment consists of a 'spacer' sequence, followed by a stretch of hydrophobic amino acids (transmembrane region) and the cytoplasmic region which differs in size between the Ig classes. Little is known about the function of intracellular tails of IgG, IgA and IgE. They differ from those of IgM and IgD, which have only three intracellular amino acids (Lys Val Lys). The intracellular parts of IgG, IgA and IgE are longer. Using a gene targeting technique by homologous recombination in ES cells [2, 3], combined with the prokaryotic CRE-recombinase system [4], we constructed two mice. One with the membrane exons and a mutated cytoplasmic tail in place (KVKdelta tail), and one with essentially only the sequence coding for the secreted form of IgE (delta M1M2). Measurements of the steady-state level of IgE showed that in delta M1M2 mice IgE can only be detected at a minimal level, whereas in KVKdelta tail mice serum IgE is reduced by about 50%. These data allow us to speculate about a specific function of the cytoplasmic tail of mIgE antibodies. We think that the cytoplasmic tail of IgE is involved in signal transduction which leads to the expression of high quantities of secreted IgE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130505     DOI: 10.1159/000237529

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

Review 1.  AllergoOncology: the role of IgE-mediated allergy in cancer.

Authors:  E Jensen-Jarolim; G Achatz; M C Turner; S Karagiannis; F Legrand; M Capron; M L Penichet; J A Rodríguez; A G Siccardi; L Vangelista; A B Riemer; H Gould
Journal:  Allergy       Date:  2008-07-26       Impact factor: 13.146

2.  Targeting the extracellular membrane-proximal domain of membrane-bound IgE by passive immunization blocks IgE synthesis in vivo.

Authors:  Stefan Feichtner; Daniela Inführ; Gertrude Achatz-Straussberger; Doris Schmid; Alexander Karnowski; Marinus Lamers; Claudio Rhyner; Reto Crameri; Gernot Achatz
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

3.  Ontogeny of human IgE-expressing B cells and plasma cells.

Authors:  F Ramadani; H Bowen; N Upton; P S Hobson; Y-C Chan; J-B Chen; T W Chang; J M McDonnell; B J Sutton; D J Fear; H J Gould
Journal:  Allergy       Date:  2016-06-08       Impact factor: 13.146

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.